Literature DB >> 16429839

Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis.

C-C Wu1, L-K Yeung, W-S Tsai, C-F Tseng, P Chu, T-Y Huang, Y-F Lin, K-C Lu.   

Abstract

BACKGROUND: Acute renal failure (ARF) is a life-threatening entity that frequently complicates advanced liver disease. This study documents a number of factors that may predispose to or precipitate ARF and influence outcomes in patients with advanced liver disease. Comparisons are also made between subgroups of patients with viral and alcohol-induced liver cirrhosis in those with ARF. PATIENTS AND METHODS: We conducted a retrospective chart review over one year of 127 consecutive hospital admissions in 82 patients who were diagnosed with advanced liver cirrhosis (Child-Pugh Class C) in a tertiary care center. A diagnosis of ARF was made in 29 admissions and another 98 admissions not complicated by ARF served as controls. This study evaluated different etiologies of ARF and developed a database which included clinical features, biochemical parameters, the etiology of cirrhosis, possible predisposing factors, and precipitating events. Version II of the Acute Physiology and Chronic Health Physiology Scoring system (APACHE II) was applied to predict short-term hospital mortality rates.
RESULTS: ARF occurred in 29 admissions over the one-year study period (23%). The mean age of these patients was 56.8 +/- 12.0 years, and 73% were men. The patients with ARF had significant hyponatremia and higher levels of serum bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and white cell counts on admission than the controls. Patients who developed ARF were more likely to have had infection, especially septicemia, and gastrointestinal (GI) bleeding. Mortality rate in the patients with ARF was much higher than in those patients without ARF (72% vs. 13%, p < 0.001). The patients with viral cirrhosis and ARF were found to have higher leukocyte counts, serum bilirubin levels, and more frequent incidence of infection, septicemia and GI bleeding compared to the patients with alcoholic liver cirrhosis and ARF. Those with viral hepatitis were also significantly older and had more frequent incidence of ascites, but had lower levels of gamma-glutamyl transpeptidase and less frequent incidence of encephalopathy.
CONCLUSIONS: The risk of ARF is significantly increased in patients with advanced liver cirrhosis presenting with marked hyperbilirubinemia, hyponatremia, elevated liver enzymes, infection, and GI bleeding. The presence of ARF leads to higher mortality rates in both viral and alcohol-induced liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16429839     DOI: 10.5414/cnp65028

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  29 in total

1.  Medical costs of abnormal serum sodium levels.

Authors:  Alisa M Shea; Bradley G Hammill; Lesley H Curtis; Lynda A Szczech; Kevin A Schulman
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

2.  Acute renal dysfunction in patients with alcoholic hepatitis.

Authors:  Robin Arora; Shweta Kathuria; Nishant Jalandhara
Journal:  World J Hepatol       Date:  2011-05-27

3.  Successful treatment with tolvaptan to control blood volume and hyponatremia in a chronic kidney disease patient.

Authors:  Tomoyuki Yamazaki; Yoshiyuki Morishita; Naoki Yoshida; Osamu Saito; Fumi Takemoto; Yasuhiro Ando; Shigeaki Muto; Wako Yumura; Eiji Kusano
Journal:  CEN Case Rep       Date:  2012-06-06

4.  Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis.

Authors:  Tomoharu Yamada; Takamasa Ohki; Yuki Hayata; Yuki Karasawa; Satoshi Kawamura; Daisaku Ito; Kentaro Kojima; Michiharu Seki; Nobuo Toda; Kazumi Tagawa
Journal:  Clin Drug Investig       Date:  2016-10       Impact factor: 2.859

Review 5.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

6.  Acute Kidney Dysfunction in Patients with Chronic Hepatitis C Virus Infection: Analysis of Viral and Non-viral Factors.

Authors:  Sanjaya K Satapathy; Chandra S Lingisetty; Susan E Williams
Journal:  J Clin Exp Hepatol       Date:  2014-02-20

Review 7.  Acute renal injury after partial hepatectomy.

Authors:  Luis Alberto Batista Peres; Luis Cesar Bredt; Raphael Flavio Fachini Cipriani
Journal:  World J Hepatol       Date:  2016-07-28

8.  Biomarkers of Renal Injury in Cirrhosis: Association with Acute Kidney Injury and Recovery after Liver Transplantation.

Authors:  Ashwani K Singal; Bradford Jackson; Glauber B Pereira; Kirk B Russ; Paul Stephen Fitzmorris; Donny Kakati; Page Axley; Sujan Ravi; Toni Seay; Satish P Ramachandra Rao; Ravindra Mehta; Yong-Fang Kuo; Karan P Singh; Anupam Agarwal
Journal:  Nephron       Date:  2017-09-02       Impact factor: 2.847

9.  Oral tolvaptan is safe and effective in chronic hyponatremia.

Authors:  Tomas Berl; Friederike Quittnat-Pelletier; Joseph G Verbalis; Robert W Schrier; Daniel G Bichet; John Ouyang; Frank S Czerwiec
Journal:  J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 10.121

Review 10.  The Kidney in Pediatric Liver Disease.

Authors:  Robyn Greenfield Matloff; Ronen Arnon
Journal:  Curr Gastroenterol Rep       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.